Literature DB >> 17431093

Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis.

Julian Gomez-Cambronero1, Mauricio Di Fulvio, Katie Knapek.   

Abstract

Phospholipase D (PLD) is an enzyme that catalyzes the conversion of membrane phosphatidylcholine to choline and phosphatidic acid (PA; a second messenger). PLD is expressed in nearly all types of leukocytes and has been associated with phagocytosis, degranulation, microbial killing, and leukocyte maturation. With the application of recently developed molecular tools (i.e., expression vectors, silencing RNA, and specific antibodies), the demonstration of a key role for PLD in those and related cellular actions has contributed to a better awareness of its importance. A case in point is the recent findings that RNA interference-mediated depletion of PLD results in impaired leukocyte adhesion and chemotaxis toward a gradient of chemokines, implying that PLD is necessary for leukocyte movement. We forecast that based on results such as those, leukocytes may prove to be useful tools to unravel still-unresolved mechanistic issues in the complex biology of PLD. Three such issues are considered here: first, whether the cellular actions of PLD are mediated entirely by PA (the product of its enzymatic reaction) or whether PLD by itself interacts with other protein signaling molecules; second, the current difficulty of defining a "PA consensus site" in the various intracellular protein targets of PA; and third, the resolution of specific PLD location (upstream or downstream) in a particular effector signaling cascade. There are reasons to expect that leukocytes and their leukemic cell line counterparts will continue yielding invaluable information to cell biologists to resolve standing molecular and functional issues concerning PLD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17431093     DOI: 10.1189/jlb.0107033

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  15 in total

1.  The molecular basis of phospholipase D2-induced chemotaxis: elucidation of differential pathways in macrophages and fibroblasts.

Authors:  Katie Knapek; Kathleen Frondorf; Jennalee Post; Stephen Short; Dianne Cox; Julian Gomez-Cambronero
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

Review 2.  The exquisite regulation of PLD2 by a wealth of interacting proteins: S6K, Grb2, Sos, WASp and Rac2 (and a surprise discovery: PLD2 is a GEF).

Authors:  Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2011-06-29       Impact factor: 4.315

3.  Biochemical characterization of a Pseudomonas aeruginosa phospholipase D.

Authors:  Cierra Spencer; H Alex Brown
Journal:  Biochemistry       Date:  2015-01-22       Impact factor: 3.162

4.  Differential Roles of Phospholipase D Proteins in FcεRI-Mediated Signaling and Mast Cell Function.

Authors:  Minghua Zhu; Jianwei Zou; Tieshi Li; Sarah A O'Brien; Yao Zhang; Sarah Ogden; Weiguo Zhang
Journal:  J Immunol       Date:  2015-09-21       Impact factor: 5.422

5.  Phospholipase D isoforms differentially regulate leukocyte responses to acute lung injury.

Authors:  Raja-Elie E Abdulnour; Judie A Howrylak; Alexander H Tavares; David N Douda; Karen M Henkels; Taylor E Miller; Laura E Fredenburgh; Rebecca M Baron; Julian Gomez-Cambronero; Bruce D Levy
Journal:  J Leukoc Biol       Date:  2018-02-13       Impact factor: 4.962

6.  Inhibition of formyl peptide-stimulated phospholipase D activation by Fal-002-2 via blockade of the Arf6, RhoA and protein kinase C signaling pathways in rat neutrophils.

Authors:  Ya-Ru Tsai; Li-Jiau Huang; Hui-Yi Lin; Yun-Jie Hung; Miau-Rong Lee; Sheng-Chu Kuo; Mei-Feng Hsu; Jih-Pyang Wang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-23       Impact factor: 3.000

7.  Phospholipase D1 is required for angiogenesis of intersegmental blood vessels in zebrafish.

Authors:  Xin-Xin I Zeng; Xiangjian Zheng; Yun Xiang; Hyekyung P Cho; Jason R Jessen; Tao P Zhong; Lilianna Solnica-Krezel; H Alex Brown
Journal:  Dev Biol       Date:  2009-02-04       Impact factor: 3.582

8.  A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.

Authors:  Qing Ye; Samuel Kantonen; Karen M Henkels; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

9.  D-series Resolvins activate Phospholipase D in phagocytes during inflammation and resolution.

Authors:  Ramya Ganesan; Karen M Henkels; Krushangi Shah; Xavier De La Rosa; Stephania Libreros; Nagarjuna R Cheemarla; Charles N Serhan; Julian Gomez-Cambronero
Journal:  FASEB J       Date:  2020-10-12       Impact factor: 5.191

10.  Phospholipase D in TCR-Mediated Signaling and T Cell Activation.

Authors:  Minghua Zhu; Daniel P Foreman; Sarah A O'Brien; Yuefei Jin; Weiguo Zhang
Journal:  J Immunol       Date:  2018-01-31       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.